Quotes Cytokinetics, Incorporated Deutsche Boerse AG
Equities
KK3A
US23282W6057
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.4 EUR | -0.80% |
|
+2.92% | -33.24% |
24/06 | JPMorgan Cuts Price Target on Cytokinetics to $65 From $77, Maintains Overweight Rating | MT |
17/06 | Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing | MT |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG25/06/2024 | 26/06/2024 | 27/06/2024 | 28/06/2024 | |
---|---|---|---|---|
Last | 49 € | 48.2 € | 49.8 € | 49.4 € |
Change | -1.21% | -1.63% | +3.32% | -0.80% |
Performance
1 day | -0.80% | ||
1 week | +2.92% | ||
Current month | +9.78% | ||
1 month | +11.76% | ||
3 months | -23.41% | ||
6 months | -33.24% | ||
Current year | -33.24% | ||
1 year | +61.44% | ||
3 years | +160.00% | ||
5 years | +418.15% | ||
10 years | +1,322.81% |
Volumes
marketsBasic data
Highs and lows
![Extreme 47.8](/images/extremecours_fleche.png)
![Extreme 43.4](/images/extremecours_fleche.png)
![Extreme 43.4](/images/extremecours_fleche.png)
![Extreme 25.2](/images/extremecours_fleche.png)
![Extreme 15.3](/images/extremecours_fleche.png)
![Extreme 7.1](/images/extremecours_fleche.png)
![Extreme 2.465](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.80% | +2.92% | -33.24% | +61.44% | 629.59Cr | ||
-0.80% | +0.00% | +15.20% | +33.62% | 12TCr | ||
+0.02% | -0.20% | +19.67% | +50.14% | 11TCr | ||
-1.87% | +9.90% | +18.95% | +16.51% | 2.6TCr | ||
-0.02% | -5.06% | -23.86% | -24.83% | 1.94TCr | ||
-1.88% | -3.38% | -19.03% | -31.05% | 1.59TCr | ||
-2.00% | -8.61% | -20.90% | -20.68% | 1.51TCr | ||
-0.36% | -3.21% | -46.14% | -37.44% | 1.51TCr | ||
+0.03% | -1.69% | +63.85% | +41.18% | 1.49TCr | ||
+2.50% | +2.30% | +4.49% | +45.19% | 1.39TCr | ||
+0.07% | -1.46% | +116.20% | +232.51% | 1.08TCr | ||
-4.14% | +0.76% | +20.24% | +46.79% | 821.51Cr | ||
-0.83% | +3.94% | -26.39% | -36.91% | 807.33Cr | ||
+2.65% | +16.29% | +139.15% | +279.79% | 905.93Cr | ||
+0.72% | +6.67% | +8.28% | +56.79% | 782.14Cr | ||
+0.96% | -1.82% | -3.56% | +25.54% | 744.99Cr | ||
Average | -0.36% | +0.97% | +14.56% | +46.16% | ||
Weighted average by Cap. | -0.44% | +0.30% | +14.79% | +38.14% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -33.24% | ||
2023 | +76.19% | ||
2022 | +3.45% | ||
2021 | +143.11% | ||
2020 | +84.53% | ||
2019 | +68.84% | ||
2018 | -22.87% | ||
2017 | -41.33% | ||
2016 | +23.90% | ||
2015 | +69.49% | ||
2014 | +17.48% | ||
2013 | +60.03% | ||
2012 | -32.16% | ||
2011 | -51.19% | ||
2010 | -19.25% | ||
2009 | +8.09% | ||
2008 | -48.97% | ||
2007 | -36.87% | ||
2006 | +32.27% |
- Stock Market
- Equities
- CYTK Stock
- KK3A Stock
- Quotes Cytokinetics, Incorporated